Iranian Journal of Diabetes and Obesity
Shahid Sadoughi University Of Medical Sciences
Tue, Nov 26, 2024
[Archive]
Volume 10, Issue 4 (10-2018)
IJDO 2018, 10(4): 194-203 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khayatan S, Aghaei A, Abedi M, Golparvar M. Effectiveness of Compassion- Acceptance and Commitment Combined Therapy with Cognitive-Behavioral Therapy on Interpersonal Forgiveness in Female Patients with Type II Diabetes. IJDO 2018; 10 (4) :194-203
URL: http://ijdo.ssu.ac.ir/article-1-449-en.html
URL: http://ijdo.ssu.ac.ir/article-1-449-en.html
Professor, Department of Educational Science and Psychology, Isfahan (Khorasgan) Branch, Islamic Azad University, Esfahan, Iran.
Abstract: (2673 Views)
Objective: Diabetes is chronic and debilitating disease that affects all aspects of a person's life. The purpose of this study was to compare the effectiveness of compassion focused (CFT)-acceptance commitment (ACT) combined therapy with cognitive-behavioral therapy (CBT), on interpersonal forgiveness in women with type II diabetes.
Materials and Methods: This was of quasi- experimental study on three groups (CFT-ACT combined therapy, a cognitive-behavioral and a control group) and three stages (pre-test, post- test and follow up). Among diabetic women population, 47 patients were selected purposefully and randomly assigned to three groups. Tow experimental groups (CFT- ACT & CBT) received 120 minutes’ sessions of CFT- ACT and CB for10 weeks. The control group did not receive any treatment .Data were analyzed by repeated measures analysis of variance using SPSS-24 software.
Results: The results showed that the scores of experimental group participants in the post test of CFT-ACT and CBT improved significantly compared to the control group in all three components of forgiveness, including reconnection and revenge control, resentment control and realistic understanding (P-value: 0/000). The experimental group of the combined therapeutic model was more effective than the CBT group in the two components of resentment control and realistic understanding.
Conclusion: Based on the findings, the combination therapy of CFT- ACT and CBT can be used to promote reconnection and revenge control, resentment control and realistic understanding in diabetic patients.
Materials and Methods: This was of quasi- experimental study on three groups (CFT-ACT combined therapy, a cognitive-behavioral and a control group) and three stages (pre-test, post- test and follow up). Among diabetic women population, 47 patients were selected purposefully and randomly assigned to three groups. Tow experimental groups (CFT- ACT & CBT) received 120 minutes’ sessions of CFT- ACT and CB for10 weeks. The control group did not receive any treatment .Data were analyzed by repeated measures analysis of variance using SPSS-24 software.
Results: The results showed that the scores of experimental group participants in the post test of CFT-ACT and CBT improved significantly compared to the control group in all three components of forgiveness, including reconnection and revenge control, resentment control and realistic understanding (P-value: 0/000). The experimental group of the combined therapeutic model was more effective than the CBT group in the two components of resentment control and realistic understanding.
Conclusion: Based on the findings, the combination therapy of CFT- ACT and CBT can be used to promote reconnection and revenge control, resentment control and realistic understanding in diabetic patients.
Keywords: Compassion-focused therapy, Acceptance and Commitment therapy, Cognitive Behavioral Therapy
Type of Study: Research |
Subject:
Special
Received: 2019/05/28 | Accepted: 2019/05/28 | Published: 2019/05/28
Received: 2019/05/28 | Accepted: 2019/05/28 | Published: 2019/05/28
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
